number of weight loss drug prescriptions q3 2024 semaglutide tirzepatide Chart: 1 in 8 Americans Now Use GLP-1 Drugs for Weight-loss drugs such as Ozempic

There were 2087 reports (14.38%) of AEs occurring in patients aged 6069 years accounting for the largest proportion of patients

As Ozempic sales began to skyrocket for this off-label use, Novo Nordisk developed and released a weight-loss specific form of the drug, known as Wegovy

Contact your obstetrician immediately

Increased risk of cholelithiasis was explained by Shaddinger et al

For some, Wegovy has been the unexpected nudge they needed to cut backor quit altogether

Research on glycine supplementation shows potential benefits for insulin sensitivity and inflammation, though whether these effects extend to glycine-tirzepatide combinations specifically remains unstudied